Could talk therapy boost brain function in schizophrenia?

NCT ID NCT07671040

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This pilot study tested whether adding structured supportive psychotherapy to the antipsychotic risperidone could improve cognitive function and reduce inflammation in 44 hospitalized adults with schizophrenia. Participants received either risperidone plus 12 weekly talk therapy sessions or risperidone plus unstructured conversation. The study measured changes in thinking skills and a blood marker of inflammation after 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
structured supportive psychotherapy
What this could lead to
If this approach works, it could point toward a way to improve thinking skills and reduce inflammation in people with schizophrenia, alongside standard medication.
What could go wrong
This is a small pilot study with only 44 participants, so results may not apply to everyone. The trial was registered after completion, which can introduce bias.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE AND EXECUTIVE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neuroinflammatory Diseases neuronitis schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Psychiatry, Faculty of Medicine, Hasanuddin University

    Makassar, South Sulawesi, 90245, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.